Purdue Pharma will pay $270 million to settle Oklahoma’s claims that illegal marketing of Oxycontin devastated local communities, the first accord in a wave of lawsuits faced by the drugmaker. Three dozen states and 1,600 U.S. cities and counties have similar suits pending against Purdue and two other opioid makers. — Josh Petri
Here are today’s top stories
Carlos Ghosn received an unusual perk during his time at Nissan. The company paid for all four of his children to attend Stanford University.
The world's cheapest hospital charges just $700 for cancer surgery. Pretty good, but under India's new health-care system, Bloomberg Businessweek reports, that's not good enough.
McDonald's is spending more than $300 million on a decision-logic tech company. The acquisition will allow the fast-food chain to vary digital menus depending on weather, time of day or regional preferences.
What’s Joe Weisenthal thinking about? The Bloomberg news director is unpacking yesterday's Apple rollout. Investors were underwhelmed by the new services the company introduced as shares fell 1.2 percent. But the bigger picture is that all of the internet giants appear to be setting up for a new battle, one where they try to block each other out.
What you’ll need to know tomorrow
What you’ll want to read in Businessweek
Extreme weather events are getting worse, and so is their impact on coastal real estate. But even as coastal housing becomes more vulnerable, the cost of living there has stayed relatively stable, and home prices continue to rise. It’s not that homebuyers are ignoring the growing threat of climate-related damage; it’s just that there are too few financial repercussions for coastal homeowners.

Like Bloomberg’s Evening Briefing? Subscribe to Bloomberg.com. You’ll get our unmatched global news coverage and two premium daily newsletters, The Bloomberg Open and The Bloomberg Close, and much, much more. See our limited-time introductory offer.
Interested in the future of health care? Sign up for Bloomberg's Prognosis. Get the latest news and analysis about the people, science and industries driving the medical economy, delivered to your mailbox weekly.
|
Nenhum comentário:
Postar um comentário